anti-CD45 ADC (ADC therapeutics/University college of London)

N/A

Report date: 2025/03/14 16:44:51

Base Information

Drug Nameanti-CD45 ADC (ADC therapeutics/University college of London)
Drug Alias Nameanti-CD45 antibody drug conjugate (ADC therapeutics/University college of London)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionLeukocyte common antigen inhibitors
TargetsLeukocyte common antigen
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdc Therapeutics Sa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A